The association between tobacco and the risk of asthma, rhinoconjunctivitis and eczema in children and adolescents: Analyses from phase three of the ISAAC programme

Thorax

Volumn 67, Issue 11, 2012, Pages 941-949

  Mitchell, Edwin A ^a   Beasley, Richard ^b   Keil, Ulrich ^c   Montefort, Stephen ^d   Odhiambo, Joseph ^e  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b MEDICAL RESEARCH INSTITUTE OF NEW ZEALAND   (New Zealand)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d UNIVERSITY OF MALTA   (Malta)

^e KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; ASTHMA; CHILD; DISEASE ASSOCIATION; ECZEMA; ENVIRONMENTAL EXPOSURE; GEOGRAPHIC DISTRIBUTION; HEALTH PROGRAM; HUMAN; INTERNATIONAL STUDY OF ASTHMA AND ALLERGIES IN CHILDHOOD STUDY; MATERNAL SMOKING; PATERNAL SMOKING; PRESCHOOL CHILD; PRIORITY JOURNAL; RHINOCONJUNCTIVITIS; RISK ASSESSMENT; SCHOOL CHILD; TYPES OF STUDY;

EID: 84868208927     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2011-200901     Document Type: Article

References (21)

1. US Department of Health and Human Services. The Health Consequences of Involuntary Exposure to Tobacco Smoke: a Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, Coordinating Center for Health Promotion, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2006.
2. Burke H, Leonardi-Bee J, Hashim A, et al. Prenatal and passive smoke exposure and incidence of asthma and wheeze: systematic review and meta-analysis. Pediatrics 2012;129:735-44.
3. Ellwood P, Asher MI, Beasley R, et al; ISAAC Steering Committee. The International Study of Asthma and Allergies in Childhood (ISAAC): Phase Three rationale and methods. Int J Tuberc Lung Dis 2005;9:10-16. (Pubitemid 40095103)
4. Beasley R, Keil U, von Mutius E, et al. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet 1998;351:1225-32.
5. Crane J, Mallol J, Beasley R, et al; International Study of Asthma and Allergies in Childhood Phase I Study Group. Agreement between written and video questions for comparing asthma symptoms in ISAAC. Eur Respir J 2003;21:455-61. (Pubitemid 36336204)
6. Aït-Khaled N, Pearce N, Anderson HR, et al; ISAAC Phase Three Study Group. Global map of the prevalence of symptoms of rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Allergy 2009;64:123-48.
7. Lai CKW, Beasley R, Crane J, et al; The ISAAC Phase Three Study Group. Global variation in the prevalence and severity of asthma symptoms: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2009;64:476-83.
8. Odhiambo J, Williams H, Clayton T, et al; ISAAC Phase Three Study Group. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol 2009;124:1251-8.
9. Beasley R, Clayton T, Crane J, et al; ISAAC Phase Three Study Group. Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6-7 years: analysis from Phase Three of the ISAAC programme. Lancet 2008;372:1039-48.
10. Hosmer DW, Lemeshow S. Confidence interval estimation of interaction. Epidemiology 1992;3:452-6.
11. Benichou J. A review of adjusted estimators of attributable risk. Stat Methods Med Res 2001;10:195-216. (Pubitemid 32586161)
12. Rönmark EP, Ekerljung L, Lötvall J, et al. Eczema among adults: prevalence, risk factors and relation to airway diseasesdresults from a large scale population survey in Sweden. Br J Dermatol. Published Online First: 28 February 2012. doi:10.1111/j.1365-2133.2012.10904.x
13. Bø K, Thoresen M, Dalgard F. Smokers report more psoriasis, but not atopic dermatitis or hand eczema: results from a Norwegian population survey among adults. Dermatology 2008;216:40-5. (Pubitemid 350158735)
14. Tanaka K, Miyake Y, Sasaki S, et al; Osaka Maternal and Child Health Study Group. Maternal smoking and environmental tobacco smoke exposure and the risk of allergic diseases in Japanese infants: the Osaka Maternal and Child Health Study. J Asthma 2008;45:833-8.
15. Sebok B, Schneider I, Harangi F; Primary Care Paediatricians in Baranya County. Familiar and environmental factors influencing atopic dermatitis in the childhood. J Eur Acad Dermatol Venereol 2006;20:418-22.
16. Kramer U, Lemmen CH, Behrendt H, et al. The effect of environmental tobacco smoke on eczema and allergic sensitization in children. Br J Dermatol 2004;150:111-18. (Pubitemid 38234014)
17. Hjern A, Hedberg A, Haglund B, et al. Does tobacco smoke prevent atopic disorders? A study of two generations of Swedish residents. Clin Exp Allergy 2001;31:908-14. (Pubitemid 34204264)
18. Magnusson LL, Olesen AB, Wennborg H, et al. Wheezing, asthma, hayfever, and atopic eczema in childhood following exposure to tobacco smoke in fetal life. Clin Exp Allergy 2005;35:1550-6.
19. Civelek E, Yavuz ST, Boz AB, et al. Epidemiology and burden of rhinitis and rhinoconjunctivitis in 9-to 11-year-old children. Am J Rhinol Allergy 2010;24:364-70.
20. Burr ML, Anderson HR, Austin JB, et al. Respiratory symptoms and the home environment in children: a national survey. Thorax 1999;54:27-32. (Pubitemid 29103747)
21. Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965;58:295-300.